No abstract available
Keywords:
Biotechnology; CKD; FGF23; Glucose; Hypoglycemic Agents; Kidney Tubules; Proximal; Renal Insufficiency, Chronic; Research Personnel; SGLT2 inhibitors; SLC5A2 protein; Sodium-Glucose Transporter 2; clinical trials; diuretics; human; nephrology; phosphate.
MeSH terms
-
Benzhydryl Compounds
-
Fibroblast Growth Factor-23
-
Glucosides
-
Homeostasis
-
Humans
-
Male
-
Nephrology*
-
Phosphates
-
Sodium-Glucose Transporter 2 Inhibitors*
Substances
-
Benzhydryl Compounds
-
FGF23 protein, human
-
Glucosides
-
Phosphates
-
Sodium-Glucose Transporter 2 Inhibitors
-
dapagliflozin
-
Fibroblast Growth Factor-23